A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma-Reference-Cited by-同舟云学术

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

Published:2015-11 Issue:2 Volume:139 Page:275-282
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Dickson Elizabeth L.,Vogel Rachel Isaksson,Gehrig Paola A.,Pierce Stuart,Havrilesky Laura,Secord Angeles Alvarez,Dottino Joseph,Fader Amanda N.,Ricci Stephanie,Geller Melissa A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference34 articles.

1. Endometrial Cancer Statistics;American Cancer Society,2014

2. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

3. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer;Amant;Gynecol. Oncol.,2005

4. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study;Major;Cancer,1993

5. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal;Mayall;Histopathology,1994

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unexpected rare uterine carcinosarcoma with neuroendocrine differentiation: Reflections on clinical diagnosis and treatment of a case report;Medicine;2024-07-12

2. Social determinants of health in uterine carcinosarcoma;Gynecologic Oncology;2024-05

3. Endometrial carcinosarcoma;International Journal of Gynecologic Cancer;2022-12-30

4. Uterine carcinosarcoma: A 10-year single institution experience;PLOS ONE;2022-07-21

5. The role of multimodal adjuvant therapy for FIGO I-II carcinosarcoma of the uterus: a systematic review;Critical Reviews in Oncology/Hematology;2022-07